Pimasertib plus gemcitabine in metastatic pancreatic adenocarcinoma: Results of a safety run-in part of a phase II trial.
Year: 2013
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Chris Verslype, Pascal Hammel, Manuel Hidalgo, Teresa Macarulla, Rocio Garcia-Carbonero, Thierry André, Marc Van Den Eynde, Berta Laquente Saez, Michele Milella, Eric Raymond, Thea Faivre, Alvin Milner, Dolores Tarabaric, Giuseppe Locatelli, Oliver von Richter, Bernard Laffranchi, Eric Van Cutsem
Institutions: Universitair Ziekenhuis Leuven, Hôpital Beaujon, Vall d'Hebron Hospital Universitari, Hospital Universitario Virgen del Rocío, Hôpital Saint-Antoine, UCLouvain, Duran i Reynals Hospital, Instituto Nazionale Tumori Regina Elena, Merck Serono S.A. (Switzerland), inVentiv Health Clinical, Merck KGaA, Darmstadt (Germany)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2785258408